Dibbern Donald A, Dreskin Stephen C
Division of Allergy and Clinical Immunology, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Drive, OP34, Portland, OR 97239-3098, USA.
Immunol Allergy Clin North Am. 2004 May;24(2):141-62, v. doi: 10.1016/j.iac.2004.01.008.
Persistent or frequent episodes of urticaria are difficult to evaluate and treat. The best test to identify most patients with a specific underlying cause (eg, physical trigger, allergen, systemic disease) likely is the taking of a careful and detailed history and performance of a physical examination by a specialist who is knowledgeable in urticarial disease. Further study of the pathogenesis and treatment of urticaria is crucial. Given the limited efficacy of presently approved antihistamine treatments and the significant side effects of steroids and cyclosporine, there is a pressing need to evaluate other anecdotally supported urticaria treatments in randomized, controlled trials.